Skip to content

Tipranavir receives US marketing approval

Generic efavirenz approved for PEPFAR use but 4 African countries reject US drug standard

XIV International HIV Drug Resistance Workshop: Entry inhibitors

XIV International HIV Drug Resistance Workshop: Clinical response

Two generic versions of nevirapine approved for PEPFAR use

TMC114 expanded access programme announced: regulatory approval to be sought early next year

First Indian generic ARV given US FDA approval

500mg Invirase tablet approved in Europe

HIV’s Tat protein protects against RNA interference